Approval · Notice of Compliance 7713 · 2006
APO-FLECAINIDE: Notice of Compliance 7713
Issued January 27, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7713
- Date
- January 27, 2006
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Antiarrhythmic agent
- Canadian reference product
- TAMBOCOR (3M Pharmaceuticals, A Division Of 3M Canada Company)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APO-FLECAINIDE | 02275538 | Marketed |
| APO-FLECAINIDE | 02275546 | Marketed |
Medicinal ingredients
- FLECAINIDE ACETATE 50 MG per TAB
- FLECAINIDE ACETATE 100 MG per TAB